{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:19:16Z","timestamp":1790320756185,"version":"4.1.0"},"reference-count":61,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,1,12]],"date-time":"2009-01-12T00:00:00Z","timestamp":1231718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2009,4]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    The survival of malignant plasma cells is a key event in disease occurrence, progression and chemoresistance. Using DNA\u2010microarrays, we analysed the expression of genes coding for 58 proteins linked with extrinsic and intrinsic apoptotic pathways, caspases and inhibitor of apoptosis proteins. We considered six memory B cells (MBC), seven plasmablasts (PPC), seven bone marrow plasma cells (BMPC) and purified myeloma cells (MMC) from 92 newly\u2010diagnosed patients. Forty out of the 58 probe sets enabled the separation of MBC, PPC and BMPC in three homogeneous clusters, characterized by an elevated expression of\n                    <jats:italic>TNFRSF10A, TNFRSF10B, BCL2A1, CASP8, CASP9<\/jats:italic>\n                    and\n                    <jats:italic>PMAIP1<\/jats:italic>\n                    genes for MBC, of\n                    <jats:italic>FAS, FADD, AIFM1, BIRC5, CASP CASP2, CASP3<\/jats:italic>\n                    and\n                    <jats:italic>CASP6<\/jats:italic>\n                    for PPC and of\n                    <jats:italic>BCL2, MCL1, BID, BIRC3<\/jats:italic>\n                    and\n                    <jats:italic>XIAP<\/jats:italic>\n                    for BMPC. Thus, B cell differentiation was associated with change of expression of pro\u2010apoptotic and anti\u2010apoptotic genes. Regarding MMC, the major finding was TRAIL upregulation that might be counteracted by a high osteoprotegerin production by BM stromal cells and a decreased expression of\n                    <jats:italic>FAS, APAF1<\/jats:italic>\n                    and\n                    <jats:italic>BNIP3<\/jats:italic>\n                    compared to normal BMPC. Out of the 40 genes,\n                    <jats:italic>CASP2<\/jats:italic>\n                    and\n                    <jats:italic>BIRC5<\/jats:italic>\n                    expression in MMC had adverse prognosis in two independent series of previously\u2010untreated patients.\n                  <\/jats:p>","DOI":"10.1111\/j.1365-2141.2008.07562.x","type":"journal-article","created":{"date-parts":[[2009,1,12]],"date-time":"2009-01-12T03:57:00Z","timestamp":1231732620000},"page":"45-58","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Gene expression of anti\u2010 and pro\u2010apoptotic proteins in malignant and normal plasma cells"],"prefix":"10.1111","volume":"145","author":[{"given":"Michel","family":"Jourdan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Reme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Goldschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Fiol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Pantesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"De Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean\u2010Fran\u00e7ois","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Hose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,3,10]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/del065"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1634\/stemcells.2006-0352"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-08-040410"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-10-4084"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-01-0034"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.10.3756"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.21.120601.141138"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.1.227"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc883"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-313X.2004.02040.x"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.3.771"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.1.194"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402875"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0305855101"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.382680.x"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.25.14863"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2000.02364.x"},{"key":"e_1_2_6_19_1","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.4049\/jimmunol.161.6.2692","article-title":"IFN\u2010alpha is a survival factor for human myeloma cells and reduces dexamethasone\u2010induced apoptosis","volume":"161","author":"Ferlin\u2010Bezombes M.","year":"1998","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-2876"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401501"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.8.2856"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200424981"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-4322"},{"key":"e_1_2_6_25_1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V72.1.219.219","article-title":"Value of beta 2\u2010microglobulin level and plasma cell labeling indices as prognostic factors in patients with newly diagnosed myeloma","volume":"72","author":"Greipp P.R.","year":"1988","journal-title":"Blood"},{"key":"e_1_2_6_26_1","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1182\/blood.V88.10.3972.bloodjournal88103972","article-title":"Interleukin\u201010 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop","volume":"88","author":"Gu Z.J.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401632"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204623"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4114"},{"key":"e_1_2_6_30_1","first-page":"65","article-title":"Tumor necrosis factor is a survival and proliferation factor for human myeloma cells","volume":"10","author":"Jourdan M.","year":"1999","journal-title":"European Cytokine Network"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4400758"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206423"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02983377"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2003.10.004"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M411180200"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.4161\/cc.3.10.1196"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404518"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1510"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208536"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-12-007971"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.3.795"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.6.2162"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-06-1984"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-11-4512"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602422"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20656"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01705.x"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-16"},{"key":"e_1_2_6_49_1","first-page":"2371","article-title":"Expression of BAX in plasma cell dyscrasias","volume":"6","author":"Renner S.","year":"2000","journal-title":"Clinical Cancer Research"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404602"},{"key":"e_1_2_6_51_1","first-page":"912","article-title":"Osteoprotegerin is a soluble decoy receptor for tumor necrosis factor\u2010related apoptosis\u2010inducing ligand\/Apo2 ligand and can function as a paracrine survival factor for human myeloma cells","volume":"63","author":"Shipman C.M.","year":"2003","journal-title":"Cancer Research"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-04-1148"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2002.01549.x"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0400782101"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.4.1113.h81602001113_1113_1122"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.04908.x"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V82.12.3712.3712"},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.12.3566.bloodjournal85123566"},{"key":"e_1_2_6_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403784"},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-1131"},{"key":"e_1_2_6_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19920315)69:6<1373::AID-CNCR2820690612>3.0.CO;2-1"},{"key":"e_1_2_6_62_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.6.1885"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2008.07562.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2008.07562.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T12:14:34Z","timestamp":1695903274000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2008.07562.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,10]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["10.1111\/j.1365-2141.2008.07562.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2008.07562.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,10]]},"assertion":[{"value":"2009-03-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}